A new, faster-spreading variant of the coronavirus has been identified in the United Kingdom, one that appears to be 70 percent more transmissible than the original virus. Although researchers have found no evidence that the new mutation has any impact on the severity of the disease or the chances ofread more
Despite the typical recovery time for a COVID-19 infection lasting only a few weeks, a growing number of coronavirus patients are reporting chronic symptoms that linger for months after their diagnoses, despite no longer testing positive for the disease, with many of them unable to resume their normal livesread more
Pharmaceutical company AstraZeneca has announced that a manufacturing error has caused what may be a fortunate discovery in regards to the COVID-19 vaccine they are producing, in that the drug may be much more effective at lower doses than anticipated. The Oxford University-developed inoculant is amongst a host of vaccine candidates thatread more
A large-scale clinical trial conducted by the World Health Organization has determined that Gilead Sciences Inc.’s remdesivir had little or no effect on COVID-19 patients’ chances of survival or length of hospital stay. The antiviral drug had been granted Emergency Use Authorization (EUA) by the Food and Drug Administration inread more